Regarding comprehensiveness of efficacy, AF-SD produced a greater increase in VEGF (89.57% vs. 41.54%) and higher neovascular density (17.3 vs. 9.8 vessels/HPF), highlighting its dual “anti-inflammatory plus pro-repair” activity. The gene discussed is VEGFA; the disease is atrial fibrillation.